Delivery Order SPE2DR25D3404-SPE2DR26F5V7U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $15,382 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL). This firm fixed-price, competitively awarded contract is scheduled for completion by December 26, 2025, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gel-One 30 mg/3 mL syringes valued at $9,122.50 with completion scheduled for October 7, 2025. This firm fixed-price delivery order, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $14,596.00. The contract represents a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $18,245.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on September 22, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 14, 2025, and carries no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $13,459.25 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 1, 2025, with completion scheduled for December 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes valued at $6,568.20 on June 2, 2025, with completion scheduled for June 24, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical medical supplies to support federal healthcare needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $4,013.90. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $18,245.00 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed price delivery order, with an ultimate completion date of September 26, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through an open procurement process. This delivery order is...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5V7UDelivery Order
On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $9,229.20 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL). This firm fixed-price delivery order is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, competed on a full and open basis for this delivery order. The company supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Gel-One is a hyaluronic acid-based viscosupplement commonly used for osteoarthritis treatment, indicating this delivery supports the Defense Health Agency's pharmaceutical supply requirements for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 1/13/26 |